[go: up one dir, main page]

DZ3083A1 - New protease inhibitor compounds, process for their preparation and pharmaceutical compositions containing them - Google Patents

New protease inhibitor compounds, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
DZ3083A1
DZ3083A1 DZ000030A DZ000030A DZ3083A1 DZ 3083 A1 DZ3083 A1 DZ 3083A1 DZ 000030 A DZ000030 A DZ 000030A DZ 000030 A DZ000030 A DZ 000030A DZ 3083 A1 DZ3083 A1 DZ 3083A1
Authority
DZ
Algeria
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
protease inhibitor
inhibitor compounds
Prior art date
Application number
DZ000030A
Other languages
French (fr)
Inventor
Robert Weils Marquis Jr
Daniel Frank Veber
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DZ3083A1 publication Critical patent/DZ3083A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/16Eight-membered rings
    • C07D313/18Eight-membered rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
DZ000030A 1999-02-19 2000-02-16 New protease inhibitor compounds, process for their preparation and pharmaceutical compositions containing them DZ3083A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12069999P 1999-02-19 1999-02-19

Publications (1)

Publication Number Publication Date
DZ3083A1 true DZ3083A1 (en) 2004-06-02

Family

ID=22392011

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000030A DZ3083A1 (en) 1999-02-19 2000-02-16 New protease inhibitor compounds, process for their preparation and pharmaceutical compositions containing them

Country Status (8)

Country Link
EP (1) EP1153022A4 (en)
JP (1) JP2002537297A (en)
AU (1) AU3235100A (en)
CO (1) CO5271679A1 (en)
DZ (1) DZ3083A1 (en)
HK (1) HK1042695A1 (en)
PE (1) PE20001486A1 (en)
WO (1) WO2000049011A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7168084B1 (en) 1992-12-09 2007-01-23 Sedna Patent Services, Llc Method and apparatus for targeting virtual objects
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
US6583137B1 (en) 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
JP2003513924A (en) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション Protease inhibitor
JP2003513971A (en) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション Protease inhibitor
IL150964A0 (en) 2000-03-21 2003-02-12 Smithkline Beecham Corp Protease inhibitors
JP2004520439A (en) * 2000-11-17 2004-07-08 メディヴィル・アクチボラグ Cysteine protease inhibitor
CA2428863A1 (en) * 2000-11-17 2002-05-23 Medivir Uk Limited Cysteine protease inhibitors
DE102004021338A1 (en) 2003-05-27 2005-03-03 Merck Patent Gmbh New pyran compounds are useful as components in liquid crystalline media, preferably in optoelectronic displays
DE502004001386D1 (en) * 2003-05-27 2006-10-19 Merck Patent Gmbh Pyranderivative with exocyclic double bond
EP1757284A1 (en) 2005-08-25 2007-02-28 Santhera Pharmaceuticals (Schweiz) AG Use of N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use
AU6252794A (en) * 1993-03-03 1994-09-26 Eli Lilly And Company Balanoids
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
AR013079A1 (en) * 1997-05-06 2000-12-13 Smithkline Beecham Corp SUBSTITUTED DERIVATIVES OF TETRAHIDROFURANO-3-ONAS, TETRAHIDROPIRANO-3- ONAS AND TETRAHIDROTIOFEN-3-ONAS, A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION OF A MEDICINAL PRODUCT USEFUL AS INTERMEDIATE PROTEIN INHIBITORS

Also Published As

Publication number Publication date
AU3235100A (en) 2000-09-04
HK1042695A1 (en) 2002-08-23
JP2002537297A (en) 2002-11-05
WO2000049011A1 (en) 2000-08-24
EP1153022A4 (en) 2002-03-27
EP1153022A1 (en) 2001-11-14
CO5271679A1 (en) 2003-04-30
PE20001486A1 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
DZ3052A1 (en) Compounds new inhibitors of metalloproteases, process for their preparation and pharmaceutical compositions containing them.
DZ2891A1 (en) New substituted tetrahydroquinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2963A1 (en) New substituted bicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2890A1 (en) 4-Carboxamino-2-substituted-1,2,3,4-tetrahydroquinoline, process for their preparation and pharmaceutical compositions containing them.
MA26659A1 (en) NOVEL BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION.
DZ2634A1 (en) New pleuromutilin derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2773A1 (en) New pyrazolopyrimidinones process for their preparation and pharmaceutical compositions containing them.
DZ2866A1 (en) New 1-Aryl-3-arylmethyl-1,8-naphthyridine-4- (1H) -ones, process for their preparation and pharmaceutical compositions containing them.
DZ3016A1 (en) Compounds new monoamine reabsorption inhibitors, process for their preparation and pharmaceutical compositions containing them.
DZ2889A1 (en) 4-Carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines, process for their preparation and pharmaceutical compositions containing them.
DZ3009A1 (en) New heteroaryl substituted quinoline-2-one derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2197A1 (en) 6-Phenylpyridyl-2-amine derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2128A1 (en) New compounds, process for their preparation and pharmaceutical compositions containing them.
DZ1889A1 (en) New quinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ3045A1 (en) Novel i-3-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2465A1 (en) New pyrazolopyrimidinones process for their preparation and compositions containing them.
DZ3020A1 (en) New oxamic acids, process for their preparation and pharmaceutical compositions containing them.
DZ3042A1 (en) New isothiazole derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2300A1 (en) Substituted 6,5-heterobicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2299A1 (en) Substituted 6,6-heterobicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2962A1 (en) New 3-azabicycloÄ3,1,0Ühexane derivatives, process for their preparation and compositions containing them.
CH689805A8 (en) Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it.
DZ1957A1 (en) New piperidine derivatives, process for their preparation and pharmaceutical compositions containing them.
MA26630A1 (en) NOVEL 4-PHENYLPYPERIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2794742B1 (en) NOVEL BENZENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME